Average Co-Inventor Count = 7.99
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (43 from 3,222 patents)
2. Santen Pharmaceutical Co., Ltd. (3 from 281 patents)
3. Genetech, Inc. (2 from 98 patents)
4. Principia Biopharma Inc. (1 from 51 patents)
49 patents:
1. 9572811 - Treatment of dry eye
2. 9452156 - Formulations and methods for vascular permeability-related diseases or conditions
3. 8486960 - Formulations and methods for vascular permeability-related diseases or conditions
4. 8222271 - Formulations and methods for vascular permeability-related diseases or conditions
5. 7777007 - PRO9907 antibodies
6. 7704498 - ErbB4 antagonists
7. 7700736 - PRO350 antibodies
8. 7582293 - Anti-PRO6308 antibodies
9. 7572447 - Methods and compositions for selective modulation of vascularization
10. 7557192 - Anti-PRO335 antibodies
11. 7504480 - PRO10275 polypeptides
12. 7470771 - Secreted and transmembrane polypeptides and nucleic acids encoding the same
13. 7456261 - PRO9830 antibodies
14. 7432345 - PRO1475 polypeptide
15. 7429641 - PRO9830 polypeptides